Work

Ivacaftor-treated Patients with Cystic Fibrosis Derive Long-Term Benefit Despite No Short-Term Clinical Improvement

Year: 2017

Type: article

Source: American Journal of Respiratory and Critical Care Medicine

DOI: 10.1164/rccm.201710-2046le

Authors: Sonya L. Heltshe, Steven M. Rowe, Michelle Skalland, Arthur Baines, Manu Jain

Institutions: University of Washington, Cystic Fibrosis Foundation, University of Alabama, University of Alabama at Birmingham, Northwestern University

Language: English

Topic: Cystic Fibrosis Research Advances

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Cystic Fibrosis Foundation, Cystic Fibrosis Foundation Therapeutics, Northwestern University, University of Washington, National Institutes of Health, Feinberg School of Medicine, National Heart, Lung, and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases, National Center for Advancing Translational Sciences

Awards: Translational Program in CFTR-Related Airway Diseases, G308544354, G3913178333, G691201058, G694332062, Center for Cystic Fibrosis Translational Research in the Post-CFTR modulator Era

OpenAlex ID: W2806303552

FWCI: 2.028

Cites: 12

Cited by: 27

Related to: 10